Difference Between covaxin and covishield – Know end to end

Difference Between covaxin and covishield

Covaxin and Covishield are both COVID-19 vaccines that have been developed and manufactured in India. Covaxin is developed by Bharat Biotech and the Indian Council of Medical Research (ICMR), while Covishield is developed by the University of Oxford and AstraZeneca, and manufactured by the Serum Institute of India.

Both vaccines are based on the same technology, called an inactivated virus platform. In this platform, the virus is killed and then used as the base for the vaccine.

While both vaccines have been authorized for emergency use in India, Covaxin is yet to release its Phase 3 clinical trial data and Covishield already done so.

Covaxin and Covishield are both COVID-19 vaccines developed in India. Covaxin is developed by Bharat Biotech and the Indian Council of Medical Research (ICMR), and Covishield is developed by the Serum Institute of India in partnership with AstraZeneca and Oxford University.

Both vaccines use a similar technology called an inactivated virus platform, which means that they use a version of the virus that has been killed to provoke an immune response. However, they use different strains of the virus. Covaxin uses the strain called BBV152, while Covishield uses the strain called AZD1222.

Both vaccines have undergone phase 3 clinical trials and have been authorized for emergency use in India. However, Covaxin has not yet been authorized for use in other countries, while Covishield has been authorized in several countries including the UK and India.

Both vaccines have shown to be safe and effective in protecting against COVID-19.